Citation Impact
Citing Papers
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
The endocannabinoid system in chronic liver disease
2005
Endocannabinoids potently protect the newborn brain against AMPA‐kainate receptor‐mediated excitotoxic damage
2006
Cannabinoid CB1 Receptor Mediates Fear Extinction via Habituation-Like Processes
2006
Role of the endocannabinoid system in Alzheimer's disease: New perspectives
2004
Supply and demand for endocannabinoids
2011
Critical period plasticity in local cortical circuits
2005 Standout
Cyclooxygenase-2 in Synaptic Signaling
2008
Gene-Targeting Technologies for the Study of Neurological Disorders
2004
Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
2008
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
2014
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
2005
Estrogen receptors and human disease
2006 Standout
Neurotrophin regulation of neural circuit development and function
2012 Standout
The safety of cannabinoids for the treatment of multiple sclerosis
2005
Adverse Health Effects of Marijuana Use
2014 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Involvement of brain‐derived neurotrophic factor in cannabinoid receptor‐dependent protection against excitotoxicity
2004
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
2005
A Chemical Glycoproteomics Platform Reveals O-GlcNAcylation of Mitochondrial Voltage-Dependent Anion Channel 2
2013 StandoutNobel
Glutamate uptake
2001 Standout
Huntington's disease
2007 Standout
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
2008
The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus
2006
Cannabinoid signaling in glial cells
2004
A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK?
2004
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation
2005
Endocannabinoid‐mediated short‐term synaptic plasticity: depolarization‐induced suppression of inhibition (DSI) and depolarization‐induced suppression of excitation (DSE)
2004
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal celldeath
2008
Nitrosative and Oxidative Injury to Premyelinating Oligodendrocytes in Periventricular Leukomalacia
2003
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
2005
Oleamide: a member of the endocannabinoid family?
2004
Isotope-targeted glycoproteomics (IsoTaG): a mass-independent platform for intact N- and O-glycopeptide discovery and analysis
2015 StandoutNobel
Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors
2006
The endocannabinoid system and its therapeutic exploitation
2004
Disruption of an Evolutionarily Novel Synaptic Expression Pattern in Autism
2016 StandoutNobel
The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells
2006
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia
2004
Gut microbiome and health: mechanistic insights
2022 Standout
Reverberation, storage, and postsynaptic propagation of memories during sleep
2004
Sexual dimorphism in predisposition to Alzheimer's disease
2018
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Inflammation and Colon Cancer
2010 Standout
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity
2005
Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances
2008 Standout
Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics
2007
Cannabinoids and Multiple Sclerosis
2007
CB1 Cannabinoid Receptors Modulate Kinase and Phosphatase Activity During Extinction of Conditioned Fear in Mice
2004
Dual alterations in casein kinase I-ε and GSK-3β modulate β-catenin stability in hyperproliferating colonic epithelia
2006
The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells
2006
Immunopathology of multiple sclerosis
2015 Standout
Glycogen Synthase Kinase-3β Inhibits the Xenobiotic and Antioxidant Cell Response by Direct Phosphorylation and Nuclear Exclusion of the Transcription Factor Nrf2
2006
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Tracking and Elucidating Alphavirus-Host Protein Interactions
2006 StandoutNobel
TRPV1 structures in distinct conformations reveal activation mechanisms
2013 StandoutNatureNobel
The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction
2008
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Regulation of CYP2C19 Expression by Estrogen Receptor α: Implications for Estrogen-Dependent Inhibition of Drug Metabolism
2010
Efficacy and safety of medical cannabinoids in older subjects: A systematic review
2014
Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know
2012
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain
2004
Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice
2004
The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
2005
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
2004
Inhibition of Fatty-Acid Amide Hydrolase Accelerates Acquisition and Extinction Rates in a Spatial Memory Task
2006
On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures
2004
Endovanilloids
2004
The therapeutic potential of G-protein coupled receptors in Huntington's disease
2010
The Ligands of Estrogen Receptor α Regulate Cytochrome P4502C9 (CYP2C9) Expression
2011
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Chronic ethanol consumption:from neuroadaptation to neurodegeneration
1998
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
ADAMs family members as amyloid precursor protein α‐secretases
2003
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Estrogen provides neuroprotection against activated microglia‐induced dopaminergic neuronal injury through both estrogen receptor‐α and estrogen receptor‐β in microglia
2005
Trolox and 17β-Estradiol Protect against Amyloid β-Peptide Neurotoxicity by a Mechanism That Involves Modulation of the Wnt Signaling Pathway
2005
Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice
2007
Endocannabinoid-Mediated Control of Synaptic Transmission
2009
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The endocannabinoid signalling system: Biochemical aspects
2005
Definition of Estrogen Receptor Pathway Critical for Estrogen Positive Feedback to Gonadotropin-Releasing Hormone Neurons and Fertility
2006
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click Chemistry
2014 StandoutNobel
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
2005
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery
2005
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Glutamate-induced increase of extracellular glutamate through N-methyl-d-aspartate receptors in ethanol withdrawal
1999
Cannabinoids and the expanded endocannabinoid system in neurological disorders
2019
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
2010
The endocannabinoid system drives neural progenitor proliferation
2005
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
2005
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis
2005
BDNF Evokes Release of Endogenous Cannabinoids at Layer 2/3 Inhibitory Synapses in the Neocortex
2010
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Endocannabinoids and Their Implications for Epilepsy
2004
Neuroprotective Therapies after Perinatal Hypoxic-Ischemic Brain Injury
2013
P2X7receptors control 2-arachidonoylglycerol production by microglial cells
2004
Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes
2004
Cooling for newborns with hypoxic ischaemic encephalopathy
2013 Standout
Experience-Dependent Plasticity of Mouse Visual Cortex in the Absence of the Neuronal Activity-Dependent Markeregr1/zif268
2001
A FAAH-Regulated Class of N-Acyl Taurines That Activates TRP Ion Channels
2006 StandoutNobel
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
2006
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
About Sleep's Role in Memory
2013 Standout
Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice
2006
SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
2011 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Inactivation of N-Acyl Phosphatidylethanolamine Phospholipase D Reveals Multiple Mechanisms for the Biosynthesis of Endocannabinoids
2006
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection
2008
Cannabinoids for Medical Use
2015 Standout
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
2005
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
2005 Science
Physiology of Microglia
2011 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
2009 StandoutNobel
Multiple Functions of Endocannabinoid Signaling in the Brain
2012
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
2004
Works of Sharon Goodenough being referenced
Kainic acid induces 14-3-3 ζ expression in distinct regions of rat brain
2002
Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes
2005
Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway
2000
Inhibition of glycogen synthase kinase 3β is involved in the resistance to oxidative stress in neuronal HT22 cells
2004
In vivo pharmacological study of spermine-induced neurotoxicity
1995
Estrogen Receptor (ER)-Mediated Transcriptional Regulation of the Human Corticotropin-Releasing Hormone-Binding Protein Promoter: Differential Effects of ERα and ERβ
2004
Differential Expression of Egr‐1‐Like DNA‐Binding Activities in the Naive Rat Brain and After Excitatory Stimulation
1997
Inactivation of glycogen synthase kinase-3β protects against kainic acid-induced neurotoxicity in vivo
2004
Estrogen Receptor α-mediated Silencing of Caveolin Gene Expression in Neuronal Cells
2002
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
2003 Science